Radiotherapy is the common modality of treatment with or without adjuvant chemotherapy. Progression to multiple myeloma is possible; thus, close follow-up of the patient is essential after completion of the therapeutic procedure.
Introduction
Plasma cell tumors consist of extra medullary plasmacytoma (EMP), multiple myeloma (MM) and solitary bone plasmacytoma (SBP). Plasmacytoma is a plasma cell neoplasm of bone marrow that is in the end stage of B lymphocyte maturation. [1] It is a solitary tumor of neoplastic monoclonal plasma cells proliferation in either bone or soft tissue that is known as EMP. [2] Solitary plasmacytoma may be an isolated tumor in any region of body or the first manifestation of a subsequent MM.
EMP comprises up to 3% of all plasma cell tumors.
These tumors are more common in men, particularly in their sixth to eighth decades of life. [3] Extramedullary lesions may occur in the absence of bone involvement, especially in the head and neck region. [4] Approximately 90% of EMPs are found in the head and neck region. They commonly involve the nasal cavity, paranasal sinuses, tonsillar fossa, and oral cavity. [4] Yoshimura et al. reported 2 cases of plasmacytoma in the oral region. [5] The etiology of this disease is still unknown, but viruses, overdose irradiation, chronic stimulation, and gene disorders in the reticuloendothelial system have been suggested as the probable etiologic factors. [6] Some authors consider it to be unrelated to MM, even though both of them are similar in microscopic view. [7] Currently, the accepted criteria obtained by using MRI, flow cytometry, and polymerase chain reaction (PCR) include the solitary extramedullary mass of clonal plasma cells, bone marrow plasma cell infiltration (≤5.0% of all nucleated cells), absence of osteolytic lesions or other tissues involvement (no evidence of myeloma elsewhere), and absence or low level of serum or urinary monoclonal immunoglobulin. [4, 8] Plasmacytomas can be graded as lesions of minimal to severe dysplasia. [1] In this article, we reported an EMP in an otherwise healthy young man.
Case Report
A 25-year-old man was referred to the Department of 
Discussion
In addition to the division mentioned at the beginning of the article, plasmacytoma traditionally is divided into medullary and extramedullary types, which can be eith- dense opacity overlying the maxillary sinus with destruction of its floor and lateral walls. [13] We reported this case because of the low age of our patient (opposed to the majority of reported cases), rare occurrence of the lesion in the maxilla, and also the rarity of extramedullary type of plasmacytoma compared with its bony type.
Plasmacytoma is clinically similar to chronic inflammatory diseases, plasma cell gingivitis, and lymphomas that are distinguishable histopathologically. In fact, microscopic view of the lesion is the only diagnostic tool for differentiating plasmacytoma from other lesions. Monoclonal proliferation is suggestive of neoplasm superimposed to inflammatory lesions. Radiographically, EMP can erode the bone and make it difficult to be distinguished from a bony lesion. [14] Solitary plasmacytoma is different from MM due to lack of plasma cell infiltration in a bone marrow biopsy. [3] Histopathologic features of EMP show a connective tissue greatly infiltrated by plasma cells which are like focal sheets, small islands, or plasmacytoid nodules.
[5] Moreover, in this report, majority of plasma cells were poorly or moderately differentiated with large and distinct nuclei, and the minorities were welldifferentiated. Since the granulomas associated with dental infection demonstrate a large number of plasma cells, special attention should be considered when diagnosing a lesion as solitary myeloma. Because of the common dense infiltration of plasma cells associated with inflammatory lesions of the oral tissues, the diagnosis of plasmacytoma and plasma cell granuloma is difficult by using only histopathologic findings. Thus, flow cytometry is recommended in such situations. [15] The rate of progression of EMP to MM is 15-20%. Harwood et al. reported the high rate of conversion to MM if EMP involved the underlying bone. [16] In some cases that were treated with radiation, 0.0-11% local recurrence was reported. In this situation, the recurrence in bone is concomitant with progression rate of multiple myeloma. [7] EMP is a rare lesion that comprises about 3% of all plasma cell neoplasms. So far, the majority of lesions have been seen in men of older ages; [3] while, our patient was a young man, which is a very rare case. Barros involved, the patient should receive adjuvant radiotherapy. [19] 
